143 related articles for article (PubMed ID: 38610869)
1. De Ritis Ratio to Predict Clinical Outcomes of Intermediate- and High-Risk Pulmonary Embolisms.
Durak K; Nubbemeyer K; Zayat R; Spillner J; Dineva S; Kalverkamp S; Kersten A
J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610869
[No Abstract] [Full Text] [Related]
2. De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction.
Steininger M; Winter MP; Reiberger T; Koller L; El-Hamid F; Forster S; Schnaubelt S; Hengstenberg C; Distelmaier K; Goliasch G; Wojta J; Toma A; Niessner A; Sulzgruber P
J Clin Med; 2018 Nov; 7(12):. PubMed ID: 30477196
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke.
Ahmadabad MA; Naeimi A; Keymoradzadeh A; Faghani S; Ahmadabad MA; Boroujeni NA; Mohammadpour H; Saberi A
BMC Neurol; 2022 Dec; 22(1):450. PubMed ID: 36463106
[TBL] [Abstract][Full Text] [Related]
4. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
[TBL] [Abstract][Full Text] [Related]
5. Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range.
Ndrepepa G; Cassese S; Scalamogna M; Lahu S; Aytekin A; Xhepa E; Schunkert H; Kastrati A
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176615
[TBL] [Abstract][Full Text] [Related]
6. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients.
Zinellu A; Arru F; De Vito A; Sassu A; Valdes G; Scano V; Zinellu E; Perra R; Madeddu G; Carru C; Pirina P; Mangoni AA; Babudieri S; Fois AG
Eur J Clin Invest; 2021 Jan; 51(1):e13427. PubMed ID: 33043447
[TBL] [Abstract][Full Text] [Related]
7. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Wang B; Hu L; Chen Y; Zhu B; Kong W; Zhu Z; Wang K; Yu Q; Zhang W; Wu G; Sun Y; Xia Z
Burns; 2022 Jun; 48(4):872-879. PubMed ID: 34456097
[TBL] [Abstract][Full Text] [Related]
8. The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients.
Drácz B; Czompa D; Müllner K; Hagymási K; Miheller P; Székely H; Papp V; Horváth M; Hritz I; Szijártó A; Werling K
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366457
[TBL] [Abstract][Full Text] [Related]
9. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
10. The reversed De Ritis ratio for predicting in-hospital mortality among intensive care patients with organophosphate poisoning.
Nafea O; Ibrahim F; Abdelhamid W
Biomarkers; 2023 Feb; 28(1):111-117. PubMed ID: 36377078
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of De Ritis ratio with aspartate aminotransferase and alanine aminotransferase within the reference range.
Ndrepepa G; Holdenrieder S; Kastrati A
Clin Chim Acta; 2023 Jan; 538():46-52. PubMed ID: 36370837
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic value of the AST/ALT ratio in patients with sepsis and septic shock.
Schupp T; Weidner K; Rusnak J; Jawhar S; Forner J; Dulatahu F; Brück LM; Hoffmann U; Bertsch T; Weiß C; Akin I; Behnes M
Scand J Gastroenterol; 2023 Apr; 58(4):392-402. PubMed ID: 36259154
[TBL] [Abstract][Full Text] [Related]
13. The De Ritis (Aspartate Transaminase/Alanine Transaminase) Ratio as a Prognosticator in Patients With End-stage Renal Disease-associated Renal Cell Carcinoma.
Ikeda T; Ishihara H; Takagi T; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Kondo T; Tanabe K
Clin Genitourin Cancer; 2020 Jun; 18(3):236-240.e1. PubMed ID: 31917171
[TBL] [Abstract][Full Text] [Related]
14. The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine:
Riedl JM; Posch F; Prager G; Eisterer W; Oehler L; Sliwa T; Wilthoner K; Petzer A; Pichler P; Hubmann E; Winder T; Burgstaller S; Korger M; Andel J; Greil R; Neumann HJ; Pecherstorfer M; Philipp-Abbrederis K; Djanani A; Gruenberger B; Laengle F; Wöll E; Gerger A
Ther Adv Med Oncol; 2020; 12():1758835919900872. PubMed ID: 32313566
[TBL] [Abstract][Full Text] [Related]
15. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
Nishikawa M; Miyake H; Fujisawa M
Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
[TBL] [Abstract][Full Text] [Related]
16. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
[TBL] [Abstract][Full Text] [Related]
17. The de ritis ratio: the test of time.
Botros M; Sikaris KA
Clin Biochem Rev; 2013 Nov; 34(3):117-30. PubMed ID: 24353357
[TBL] [Abstract][Full Text] [Related]
18. An Updated Systematic Review and Meta-Analysis of the Association between the De Ritis Ratio and Disease Severity and Mortality in Patients with COVID-19.
Mangoni AA; Zinellu A
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374107
[TBL] [Abstract][Full Text] [Related]
19. The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
Guner E; Seker KG; Arikan Y; Huseynov C; Sam E; Ozdal OL
Aktuelle Urol; 2020 Jun; 51(3):285-289. PubMed ID: 32135561
[TBL] [Abstract][Full Text] [Related]
20. The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.
Wang L; Xu Y; Zhang S; Bibi A; Xu Y; Li T
Front Cell Infect Microbiol; 2022; 12():725642. PubMed ID: 35211422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]